栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/10/26 | 2,453 | 2,468 | 2,415 | 2,419 | ±0 | ±0% | 94,200 |
| 2026/10/23 | 2,484 | 2,484 | 2,414 | 2,419 | -15 | -0.6% | 115,300 |
| 2026/10/22 | 2,443 | 2,458 | 2,414 | 2,434 | +17 | +0.7% | 152,100 |
| 2026/10/21 | 2,428 | 2,458 | 2,398 | 2,417 | +6 | +0.2% | 167,900 |
| 2026/10/20 | 2,482 | 2,487 | 2,382 | 2,411 | -76 | -3.1% | 207,700 |
| 2026/10/19 | 2,540 | 2,542 | 2,471 | 2,487 | -33 | -1.3% | 77,500 |
| 2026/10/16 | 2,500 | 2,545 | 2,490 | 2,520 | +20 | +0.8% | 151,900 |
| 2026/10/15 | 2,457 | 2,510 | 2,437 | 2,500 | +43 | +1.8% | 186,200 |
| 2026/10/14 | 2,431 | 2,463 | 2,400 | 2,457 | +20 | +0.8% | 95,700 |
| 2026/10/13 | 2,435 | 2,481 | 2,403 | 2,437 | +1 | ±0% | 215,000 |
| 2026/10/09 | 2,352 | 2,447 | 2,338 | 2,436 | +73 | +3.1% | 258,500 |
| 2026/10/08 | 2,369 | 2,386 | 2,340 | 2,363 | -4 | -0.2% | 144,400 |
| 2026/10/07 | 2,330 | 2,377 | 2,329 | 2,367 | +31 | +1.3% | 133,200 |
| 2026/10/06 | 2,279 | 2,344 | 2,258 | 2,336 | +80 | +3.5% | 100,500 |
| 2026/10/05 | 2,256 | 2,256 | 2,226 | 2,256 | +8 | +0.4% | 80,300 |
| 2026/10/02 | 2,275 | 2,310 | 2,233 | 2,248 | -59 | -2.6% | 129,900 |
| 2026/10/01 | 2,320 | 2,320 | 2,278 | 2,307 | -1 | ±0% | 83,200 |
| 2026/09/30 | 2,268 | 2,318 | 2,258 | 2,308 | +57 | +2.5% | 94,000 |
| 2026/09/29 | 2,319 | 2,321 | 2,238 | 2,251 | -101 | -4.3% | 107,300 |
| 2026/09/28 | 2,400 | 2,400 | 2,339 | 2,352 | -39 | -1.6% | 123,800 |
| 2026/09/25 | 2,399 | 2,409 | 2,374 | 2,391 | +3 | +0.1% | 112,600 |
| 2026/09/24 | 2,360 | 2,394 | 2,354 | 2,388 | +18 | +0.8% | 113,900 |
| 2026/09/18 | 2,340 | 2,377 | 2,326 | 2,370 | +9 | +0.4% | 175,200 |
| 2026/09/17 | 2,305 | 2,365 | 2,305 | 2,361 | +81 | +3.6% | 302,500 |
| 2026/09/16 | 2,272 | 2,280 | 2,247 | 2,280 | +20 | +0.9% | 102,500 |
| 2026/09/15 | 2,258 | 2,275 | 2,245 | 2,260 | +5 | +0.2% | 99,200 |
| 2026/09/14 | 2,216 | 2,255 | 2,216 | 2,255 | +39 | +1.8% | 97,900 |
| 2026/09/11 | 2,205 | 2,228 | 2,196 | 2,216 | -21 | -0.9% | 130,100 |
| 2026/09/10 | 2,236 | 2,247 | 2,213 | 2,237 | -25 | -1.1% | 91,800 |
| 2026/09/09 | 2,252 | 2,286 | 2,235 | 2,262 | -1 | ±0% | 250,200 |
| 2026/09/08 | 2,265 | 2,283 | 2,250 | 2,263 | -16 | -0.7% | 112,000 |
| 2026/09/07 | 2,321 | 2,336 | 2,265 | 2,279 | -62 | -2.6% | 185,400 |
| 2026/09/04 | 2,301 | 2,357 | 2,291 | 2,341 | +17 | +0.7% | 142,500 |
| 2026/09/03 | 2,329 | 2,337 | 2,292 | 2,324 | -5 | -0.2% | 145,100 |
| 2026/09/02 | 2,342 | 2,368 | 2,312 | 2,329 | -13 | -0.6% | 192,600 |
| 2026/09/01 | 2,350 | 2,367 | 2,313 | 2,342 | +17 | +0.7% | 197,100 |
| 2026/08/31 | 2,282 | 2,335 | 2,267 | 2,325 | +27 | +1.2% | 1,178,200 |
| 2026/08/28 | 2,301 | 2,346 | 2,282 | 2,298 | -9 | -0.4% | 123,800 |
| 2026/08/27 | 2,350 | 2,352 | 2,274 | 2,307 | -43 | -1.8% | 214,700 |
| 2026/08/26 | 2,333 | 2,362 | 2,333 | 2,350 | +11 | +0.5% | 82,500 |
| 2026/08/25 | 2,354 | 2,378 | 2,338 | 2,339 | -7 | -0.3% | 85,200 |
| 2026/08/24 | 2,358 | 2,377 | 2,306 | 2,346 | -32 | -1.3% | 239,600 |
| 2026/08/21 | 2,350 | 2,392 | 2,348 | 2,378 | +19 | +0.8% | 132,600 |
| 2026/08/20 | 2,285 | 2,359 | 2,284 | 2,359 | +65 | +2.8% | 150,700 |
| 2026/08/19 | 2,308 | 2,320 | 2,276 | 2,294 | -21 | -0.9% | 115,700 |
| 2026/08/18 | 2,315 | 2,347 | 2,276 | 2,315 | -27 | -1.2% | 133,300 |
| 2026/08/17 | 2,296 | 2,346 | 2,276 | 2,342 | +55 | +2.4% | 151,500 |
| 2026/08/14 | 2,275 | 2,315 | 2,261 | 2,287 | +11 | +0.5% | 179,300 |
| 2026/08/13 | 2,260 | 2,276 | 2,235 | 2,276 | +16 | +0.7% | 168,000 |
| 2026/08/12 | 2,267 | 2,292 | 2,231 | 2,260 | +1 | ±0% | 144,300 |
1~
50
件表示中 / 7306件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 241,900円 | +0.2% | +2.0% | 2.40% | 38.56倍 | 1.82倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
| 持田薬 | 327,500円 | +7.7% | +11.7% | 2.60% | 11.50倍 | 0.82倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 203,000円 | +6.6% | +17.7% | 2.46% | 8.95倍 | 0.83倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| サンバイオ | 90,000円 | - | - | 0.00% | - | 6.13倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 杏林製薬 | 113,300円 | -3.5% | -42.9% | 2.21% | 43.39倍 | 0.46倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム